• Busca persones
• Intranet

Malalties inflamatòries i neoplàsiques dermatològiques Ramon Mª Pujol

Publicacions 2025 (32)

• Berna-Rico E, Pesqué D, Martin-Ezquerra G, Planella-Fontanillas N, Pujol RM, Gallardo F, Giménez-Arnau AM^*. Localised Hypersensitivity Reaction to Polysorbate 80 During Secukinumab Treatment: A Case of Injection-Site Contact Urticaria. Contact Dermatitis 2025: (en Premsa).
• Starace M, Rapparini L^*, Cedirian S, Quadrelli F, Pampaloni F, Bruni F, Misciali C, Piraccini BM, Apalla Z, Fattore D, Segura S, Koumaki D, Mavroudis D, Iorizzo M, Elshot YS, Freites-Martinez A, Sollena P, Delli F, Jaka A, Nikolaou V, Giacchero D, Riganti J, Sibaud V. Erosive pustular dermatosis of the scalp due to EGFR inhibitors: A multicentric study by EADV task force of 'Dermatology for Cancer Patients'. J Eur Acad Dermatol Venereol 2025: (en Premsa).
• Angel-Baldo J^*, Podlipnik S, Azón A, Boada A, Arrieta A, Marcoval J, López-Sanchez C, Sàbat M, Segura S, Bodet D, Curcó N, Lopez-Castillo D, Solà J, Quintana-Codina M, Baliu Piqué C, Just-Sarobé M, Martín-Sala S, Malvehy J, Puig S, Carrera C^*, Marti RM, Network of Melanoma Centers in Catalonia. Acral Melanoma in the Caucasian Population: A Comprehensive Cohort Study on Epidemiological, Clinicopathological, and Prognostic Features. Actas Dermosifiliograf 2025; 116(5): T462-T473 (en Premsa).
• Hernández-Fernández CP^*, Borrego L, Giménez-Arnau AM, Sanz-Sánchez T, Carrascosa-Carrillo JM, Zaragoza-Ninet V, Serra-Baldrich E, Miquel FJ, Silvestre-Salvador JF, Cordoba-Guijarro S, Sánchez-Gilo A, Mercader-García P, Navarro-Triviño FJ, Tous-Romero F, Rodríguez-Serna M, Melé-Ninot G, Ruiz-González I, Gómez-de-la-Fuente E, Pastor-Nieto MA, Sánchez-Pedreño P, Sánchez Pérez J, Pereyra-Rodriguez JJ, Gatica-Ortega ME, González-Pérez R, García-Doval I, Gallego-Descalzo MA. Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) still be part of the Baseline Series?. Actas Dermosifiliograf 2025: (en Premsa).
• Ceravalls J^*, Giménez-Arnau AM, Expósito-Serrano V, Fernández N, Lara-Moya A, Bielsa I, Ribó P, Mascaró-Hereza B, Bonfill-Ortí M, Spertino J, Serra E, Baliu Piqué C, Melé-Ninot G. Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study. Actas Dermosifiliograf 2025: (en Premsa).
• Carnero-González L, Garcias-Ladaria JG, Rivera-Diaz R, Bassas-Vila J, Salgado-Boquete L, Masferrer E, Molina-Leyva A, Perandones-González H, de Lucas AM, Pascual JC, Mendieta-Eckert M, Martín-Ezquerra G, Garbayo-Salmons P, Nieto-Benito LM, Romaní J, Escutia B, Herrera-Acosta E, Vilarrasa E, Luque-Luna M, Pericet-Fernández LM, Rodríguez-García F, No-Pérez N, Gracia-Darder I, Falkenhain-López D, Mora-Fernández V, Oro-Ayude M, Corral-Magaña O, Grau-Pérez M^*, Martorell A, en nombre del Grupo de Trabajo REHS. Spanish Hidradenitis Suppurativa Registry (REHS) of the Spanish Academy of Dermatology and Venereology: description and data from its first year of operation. Actas Dermosifiliograf 2025; 116(6): 567-574.
• Planella-Fontanillas N, March-Rodriguez A, Pérez-Jurado LA, Abreu-Rodríguez I, Pujol RM^*, Curto-Barredo L. Palmoplantar keratoderma, knuckle pads, and syndactyly associated with a new missense variant in the SLURP1 gene. Int J Dermatol 2025; 64: 1131-1133.
• Angel-Baldo J^*, Podlipnik S, Azón A, Boada A, Arrieta A, Marcoval J, López-Sanchez C, Sàbat M, Segura S, Bodet D, Curcó N, Lopez-Castillo D, Solà J, Quintana-Codina M, Baliu Piqué C, Just-Sarobé M, Martín-Sala S, Malvehy J, Puig S, Carrera C, Marti RM, Network of Melanoma Centers in Catalonia. Acral Melanoma in the Caucasian Population: A Comprehensive Cohort Study on Epidemiological, Clinicopathological, and Prognostic Features. Actas Dermosifiliograf 2025; 116(5): 462-473.
• Metz M^*, Giménez-Arnau AM, Hide M, Lebwohl M, Mosnaim G, Saini S, Sussman G, Szalewski R, Haemmerle S, Lheritier K, Martzloff ED, Seko N, Wang P, Zharkov A, Maurer M^*, REMIX-2 Investigators. Remibrutinib in Chronic Spontaneous Urticaria. New Engl J Med 2025; 392(10): 984-994.
• Pesqué D, Silvestre-Salvador JF, Figueiredo AC, Pujol RM, Gonçalo M^*, Giménez-Arnau AM^*. A Review of Hand Eczema Subtypes: Clinical Features, Biomarkers and Treatment Strategies. Contact Dermatitis 2025; 92(6): 421-435.
• Apfelbacher C^*, Bewley A, Molin S, Fargnoli MC, Giménez-Arnau AM, Brignoli L, Rault B, Norlin JM, Skaaby T, Crépy MN. Prevalence of Chronic Hand Eczema in adults: A cross-sectional survey of over 60,000 respondents in the general population in Canada, France, Germany, Italy, Spain, and the United Kingdom. Br J Dermatol 2025; 192(6): 1047-1054.
• Escolà H^*, Mohammad N, Pujol RM. [Translated article] Multiple Yellowish Papules on the Scalp. Actas Dermosifiliograf 2025; 116(5): T535-T537.
• Zuberbier T^*, Giménez-Arnau AM, Maurer M. Predictive model to differentiate chronic histaminergic angioedema and chronic spontaneous urticaria with angioedema. J Allergy Clin Immunol 2025; 4(2): 100389 (Acceptat).
• Wilkinson SM^*, Aerts O, Agner T, Bruze M, Brans R, Foti C, Giménez-Arnau AM, Stingeni L, Svedman C. Contact Allergy to Methacrylate Containing Nail Products: Lack of Impact of EU Legislation. An Audit on Behalf of the European Environmental Contact Dermatitis Research Group (EECDRG). Contact Dermatitis 2025; 92(4): 283-290.
• Peris-Espino V^*, Munera-Campos M, Chicharro P, Gonzalez-Quesada A, Florez-Menéndez A, De la Cueva-Dobao P, Giménez-Arnau AM, Gilaberte-Calzada Y, Rodríguez-Serna M, Montero-Vilchez T, Silvestre-Salvador JF, Ruiz-Villaverde R, Elosua-González M, del Alcázar-Viladomiu E, Sánchez Pérez J, Carretero-Hernández G, Batalla A, Suh Oh, Couselo-Rodríguez C, Mauleón-Fernández C, Curto-Barredo L, Bertolín M, Navarro-Bielsa A, Ballano-Ruiz A, Botella-Estrada R, Arias-Santiago S, Sanabria-de-la-Torre R, Betlloch-Mas I, Navarro-Triviño FJ, Rouston-Gullon G, Rosell-Díaz A, Loro-Pérez M, Suarez-Perez J, García-Doval I, Descalzo-Gallego MÁ, Carrascosa-Carrillo JM. [Translated article] Clinical-Epidemiological Profile, and Treatment Response in Relation to Associated Atopic Comorbidity in Atopic Dermatitis. Experience From the BIOBADATOP Registry. Actas Dermosifiliograf 2025; 116(4): T337-T348.
• Verdaguer-Faja J, Guerra-Amor Á, Ferrandiz-Pulido C, Abril-Pérez C, Botella-Estrada R, Masferrer E, Lopez-Castillo D, Deza G, Leal L, Marti-Marti I, Ruiz-Salas V, Yébenes M, Marqués-Martin L, Baliu C, Castany A, Boada A, Toll A, Jaka A^*. Histological deep margins in cutaneous squamous cell carcinoma of the scalp and risk of recurrence. J Eur Acad Dermatol Venereol 2025; 39(4): 855-864.
• Ceravalls J^*, Ruiz-Villaverde R, Armesto S, Fernández-Armenteros JM, Riera-Monroig J, Gracia-Cazaña T, Quintana-Codina M, Iglesias-Sancho M, Salleras M, Imbernón-Moya A, Melgosa-Ramos FJ, Ferran M. Anti-IL-23 therapy for the treatment of moderate-to-severe inverse psoriasis: A 52-week multicentre study. J Eur Acad Dermatol Venereol 2025; 39(3): e290-e292.
• Sousa-Pinto B^*, Ramanauskaite A, Neisinger S, Witte-Händel E, Giménez-Arnau AM, Guillet C, Parisi CAS, Katelaris CH, Fomina D, Larenas-Linnemann D, García E, Kocatürk E, Siebenhaar F, Lima H, Kaidashev I, Nasr I, Ogueta-Canales I, Cherrez-Ojeda I, Hébert J, Bousquet J, Bernstein JA, Peter J, Sánchez J, Larco-Sousa JI, Kulthanan K, Weller K, Godse K, Rutkowski K, Lapina L, Bouillet L, Han L, Ensina LF, Gonçalo M, Magerl M, Van Doorn M, Metz M, Khoshkhui M, Hide M, Türk M, Kurjane N, Conlon N, Salameh P, Kolkhir P, Asero R, Stepanenko R, Altrichter S, Gil-Mata S, Thomsen SF, Zuberbier T, Tsaryk V, Ye YM, Brzoza Z, Zhao Z, Maurer M. Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study. Allergy 2025; 80(3): 750-761.
• Giménez-Arnau AM^*, Balp MM, Danyliv A, Winders T, O'donoghue J, Kleebach J, Morrison S, Walsh S, Mueller M, Lopez-Ortiz D, Maurer M, Bernstein JA. Assessing Preferences of Patients with Chronic Spontaneous Urticaria for Injectable Treatment Profiles. Patient . 2025; 18(2): 173-185.
• Rayinda T, Dand N, Mcsweeney SM, Christou E, Ung CY, Stefanato CM, Fenton DA, Harries M, Palamaras I, Tidman A, Holmes S, Koutalopoulou A, Ardern-Jones M, Kaur M, Papanikou S, Chasapi V, Vañó-Galvan S, Saceda-Corralo D, Melián-Olivera A, Azcarraga-Llobet C, Lobato A, Bustamante M, Sunyer J, Starace MVR, Piraccini BM, Pupo-Wiss I, Senna MM, Singh R, Hillmann K, Kanti-Schmidt V, Blume-Peytavi U, Mcgrath JA, Simpson MA, Tziotzios C. Epistasis of ERAP1 With 4 Major Histocompatibility Complex Class I Alleles in Frontal Fibrosing Alopecia: A Genome-Wide Association Study Meta-Analysis. JAMA Dermatol 2025; 161(3): 310-314.
• Parra-Navarro L^*, March-Rodriguez A, Planella-Fontanillas N, Pujol RM. [Translated article] Infantile Hemangiomas of the Vulvar Region: A Therapeutic Challenge. Actas Dermosifiliograf 2025; 116(3): T316-T319.
• March-Rodriguez A^*, Lobato A, Pujol RM. Recurrent aphthous stomatitis in a child successfully treated with apremilast. Pediatr Dermatol 2025; 42(1): 194-195.
• Soegiharto R^*, Alizadeh-Aghdam M, Sørensen JA, Van Lindonk E, Bulut-Demir F, Mohammad N, Matsuo Y, Kiefer L, Knulst AC, Maurer M, Ritchie C, Rudenko M, Kocatürk E, Criado RFJ, Gregoriou S, Bobylev T, Kleinheinz A, Takahagi S, Hide M, Giménez-Arnau AM, Salman A, Kara RO, Dikicier BS, Van Doorn MBA, Thomsen SF, van den Reek JMPA, Röckmann H. Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study. Allergy 2025; 80(2): 489-499.
• Planella-Fontanillas N, Bosch-Amate X, Jiménez-Antón A, Moreno-Vílchez C, Guerrero MG, Del Mar Blanes Martínez M, Ballester-Martínez A, Bassas-Freixas P, Castaño-Fernández JL, Estébanez-Corrales A, Suarez Fernández R, Santos-Alarcón S, Bauza-Aonso A, Torrent M, Ballano-Ruiz A, Collantes-Rodríguez C, España A, Fonseca-Capdevila E, Gil I, Hernández-Fernández CP, Melgosa-Ramos FJ, Spertino J, Zaragoza-Ninet V, Armillas L, Bielsa I, Carrera C, Rafat ME, Fulgencio-Barbarin J, Fernández-Vela J, Lova-Navarro M, Martín-Callizo C, Martín-Sala S, Ojeda R, Parera E, Puigdollers AS, Pujol RM, Podlipnik S, Mascaró JM^*, Curto-Barredo L. Real-World Evaluation of the Effectiveness and Safety of Dupilumab in Bullous Pemphigoid: An Ambispective Multicenter Case Series. Br J Dermatol 2025; 192(3): 501-509.
• Martorell A^*, Santos-Alarcón S, Sahuquillo-Torralba A, Rivera-Diaz R, Belinchón-Romero I, Ruiz-Genao D, Romero-Maté A, Ruiz-Villaverde R, Ferran M, Gallardo F, Almenara-Blasco M, Suarez-Perez JA, González-Cantero Á, Martínez-Lorenzo E, Fernández-Armenteros JM, del Alcázar-Viladomiu E, García-Latasa J, Rocamora-Durant V, Jara-Martín M, Mateu-Puchades A, Llamas-Velasco M, Vilarrasa E, Velasco-Pastor M, De la Cueva P, Carrascosa JM, Magdaleno-Tapial J. Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study. Actas Dermosifiliograf 2025; 116(2): 125-133.
• Abril-Pérez C, Mansilla-Polo M^*, Escutia-Muñoz B, Sanmartín O, Garcés JR, Rodríguez-Prieto MA, Ruiz-Salas V, de Eusebio Murillo E, Miñano R, Gonzalez-Sixto B, Artola Igarza JL, Alfaro Rubio A, Redondo P, Delgado-Jiménez Y, Sánchez J, Allende Markixana I, Alonso-Pacheco ML, Garcia-Bracamonte B, De la Cueva-Dobao P, Navarro R, Ciudad-Blanco C, Carnero-González L, Vázquez-Veiga H, Cano-Martinez N, Serra-Guillén C, Vilarrasa E, Sánchez-Sambucety P, López-Estebaranz JL, Florez-Menéndez A, Martorell-Calatayud A, Gil P, Morales-Gordillo V, Toll A, Ocerin-Guerra I, Mayor Arenal M, Suarez Fernández R, Sainz-Gaspar L, Descalzo MA, García-Doval I, Botella-Estrada R, REGESMOHS (Registro Español de Cirugía de Mohs). Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery). J Eur Acad Dermatol Venereol 2025; 39(2): 426-434.
• Starace M, Cedirian S, Rapparini L, Pileri A, Carrera C, Giavedoni P, Alonso-de Leon MT, Kraehenbuehl L, Elshot YS, Apalla Z, Papegeorgiou C, Nikolaou V, Radevic T, Lengyel Z, Sollena P, Peris K, Rossi E, Fattore D, Koumaki D, Boada A, Forsea AM, Segura S, Freites-Martinez A, Riganti J, Avitan-Hersh E, Saffuri N, Peuvrel L, Dezoteux F, Piraccini BM, Sibaud V. Immune Checkpoint Inhibitor-Induced Vitiligo-Like Depigmentation. JAMA Dermatol 2025; 161(2): 216-218.
• Pesqué D^*, Borrego L, Zaragoza-Ninet V, Sanz-Sánchez T, Miquel FJ, González-Pérez R, Silvestre JF, Cordoba-Guijarro S, Carrascosa JM, Gatica-Ortega ME, Ruiz-González I, Mercader-García P, Tous-Romero F, Ortiz de Frutos FJ, Serra-Baldrich E, Pastor-Nieto MA, Rodríguez-Serna M, Sánchez Pérez J, Sánchez-Gilo A, Melé-Ninot G, Sánchez-Pedreño P, Pujol RM, Giménez-Arnau AM^*. Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019-2022 prospective study with cluster and network analysis. J Eur Acad Dermatol Venereol 2025; 39(1): 126-136.
• Ceravalls J^*, Pérez-Muñoz N, Sola MÁ, Gallardo F, Colomo L, Pujol RM. Asymptomatic evanescent plaques on the buttocks of an elderly woman. Int J Dermatol 2025; 64(1): 79-81.
• Podder I, Pesqué D, Carrón N, Gonzalez-Torres P, Pujol RM, Giménez-Arnau AM^*. Gut microbial alteration in chronic spontaneous urticaria unresponsive to second generation antihistamines and its correlation with disease characteristics- a cross-sectional case-control study. Clin Transl Allergy 2025; 15(1): e70027.
• Garbayo-Salmons P^*, Vilarrasa E, Bassas-Vila J, Mora-Fernández V, Fuertes I, Luque-Luna M, Fornons-Servent R, Martín-Ezquerra G, Aguayo-Ortiz RS, Ceravalls J, Mollet J, Gómez-Tomás A, Masferrer E, Corral-Magaña O, Matas-Nadal C, Del Estal J, Fuertes-Bailón D, Calvet J, Romaní J. Real-world adalimumab survival and discontinuation factors in hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2025; 39(1): 221-229.
• Mateu-Arrom L^*, Giménez-Arnau AM, Expósito-Serrano V, Bonfill-Ortí M, Serra-Baldrich E, Yelamos O, Spertino J. Cyclosporine for the treatment of chronic spontaneous urticaria refractory to antihistamines and omalizumab: a case series. Int J Dermatol 2025; 64(1): 219-220.